Rechercher

Every 26 June, the International Day against Drug Abuse and Illicit Trafficking seeks to raise awareness of the problems, challenges and nefarious effects of illicit drugs (hereinafter referred to as drugs) on individuals and on society as whole. Drugs are an increasingly complex security, social and health problem that affects millions of people in the European Union (EU) and globally. The drug market generates huge profits for organised crime, and is estimated to be the source of approximately ...

En janvier 2022, la Commission européenne a proposé de renforcer le mandat de l’Observatoire européen des drogues et des toxicomanies (OEDT) afin de donner les moyens à l’Agence de réagir avec efficacité, de mieux soutenir les États membres et de contribuer à faire évoluer la situation sur le plan international. Lors de la session plénière de juin 2023, le Parlement européen devrait approuver l’accord provisoire résultant de négociations interinstitutionnelles.

Improving the EU's response to the rapid spread of new psychoactive substances has become urgent, and consequently Parliament is due to vote on a 'drugs package' during the October II plenary session. The package makes additions to the directive setting common minimum rules on criminal acts and penalties in the field of illicit drug trafficking, as well as corresponding amendments to the founding regulation of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Drug disorders are complex social and health problems that affect millions of people in the EU. In the last two decades, we have witnessed an extraordinary growth in computer and mobile technologies available to the general public. Researchers in the field of drug addiction have started to exploit the growth of the internet and new technologies, and an increasing number of interventions designed to promote changes in substance use disorders are now available. The study includes an extensive critical ...

This study, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of the LIBE Committee, provides an overview of the drug policies in international fora, at EU level, in seven Member States and in three non-EU countries. The study highlights the very different approaches taken and their varying level of effectiveness.

This note seeks to provide an initial analysis of the strengths and weaknesses of the European Commission's Impact Assessment (IA) accompanying the proposed changes to the Council Decision on the definition of drugs and a proposed new Regulation on emerging psychoactive substances, submitted on 17 September 2013. It analyses whether the principal criteria laid down in the Commission’s own Impact Assessment Guidelines, as well as additional factors identified by the Parliament in its Impact Assessment ...

The EU has a central place on the world's map of illegal drug consumption and production. Whereas the use of ""established"" drugs has stabilised in the EU, drug control authorities have increasingly been struggling with the emergence of new psychoactive substances which reproduce the effects of illegal drugs. The UN has created an international system defining drugs of which the production and sale are prohibited. All EU Member States (MS) are parties to the relevant UN conventions. In the EU, drug ...

La note de briefing présente une évaluation préliminaire de la mise en oeuvre du Plan d'Action Drogues de l'UE 2005-2008 et de l'efficacité des politiques de l'UE dans le secteur de la drogue. La note de briefing fait certaines recommandations politiques pour des actions futures au niveau de l'UE dans le domaine de la drogue, en prenant aussi en compte les données reçues par EUROPOL et l'Observatoire Européen des Drogues et des Toxicomanies. En décembre 2004, le Conseil européen a approuvé la deuxième ...